This year’s “Saving by Shaving” flagship event organized by Granite Telecommunications raised 6.5 million dollars for Dana-Farber cancer research. Granite staff along with local celebrities and government officials shaved their heads in a show of solidarity for patients undergoing cancer treatment. In return, the Hale family made a gift to…
Drs. Wolpin, Hahn, and Aguirre published a study in JAMA Oncol that reported on the survival from pancreatic cancer with different genetic alterations (Qian ZR, et al., Association of Alterations in Main Driver Genes with Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2017).
Dr. Wolpin receives news that his Lustgarten grant has been selected for funding.
Drs. Hahn, Aguirre, and Dougan receive news that their grant application on pancreatic ductal adenocarcinoma and the tumor microenvironment has been funded by the NIH (U01 CA224146-01).
Dr. Wolpin published a study in J Clin Oncol demonstrating that cigarette smoking is associated with reduced survival from pancreatic cancer(Yuan C, et al., Cigarette Smoking and Pancreatic Cancer Survival. J Clin Oncol. 2017;35(16):1822-8.).
Dr. Wolpin is appointed as the new Director of the Gastrointestinal Cancer Center.
Dr. Wolpin is appointed as the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute.
Drs. Hahn and Aguirre published in Cell Rep that the ATXN1L-CIC-ETS transcription factor axis modulates sensitivity to MAPK pathway inhibition (Wang B, et al., ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition. Cell Rep. 2017;18(6):1543-57.).